Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine 2001 September;45(3)

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

 

The Quarterly Journal of Nuclear Medicine 2001 September;45(3)

  PET IN ONCOLOGY
Guest Editor: I. Carrio

The Quarterly Journal of Nuclear Medicine 2001 September;45(3):209-14

The Internet: the road to more effective PET

Wagner H. N. Jr.

Abstract PDF

  PET IN ONCOLOGY
Guest Editor: I. Carrio

The Quarterly Journal of Nuclear Medicine 2001 September;45(3):215-30

The clinical application of positron emission tomography to colorectal cancer management

Arulampalam T. H. A., Costa D. C., Bomanji J. B., Ell P. J.

Abstract PDF

  PET IN ONCOLOGY
Guest Editor: I. Carrio

The Quarterly Journal of Nuclear Medicine 2001 September;45(3):231-4

PET in lung cancer staging

Coleman R. E.

Abstract PDF

  PET IN ONCOLOGY
Guest Editor: I. Carrio

The Quarterly Journal of Nuclear Medicine 2001 September;45(3):235-44

Local detection of prostate cancer by positron emission tomography with 2-fluorodeoxyglucose: comparison of filtered back projection and iterative reconstruction with segmented attenuation correction

Turlakow A., Larson S. M., Coakley F., Akhurst T., Gonen M., Macapinlac H. A., Kelly W., Leibel S., Humm J., Scardino P., Scher H., Hricak H.

Abstract PDF

  PET IN ONCOLOGY
Guest Editor: I. Carrio

The Quarterly Journal of Nuclear Medicine 2001 September;45(3):245-56

PET imaging in breast cancer

Bombardieri E., Crippa F.

Abstract PDF

  PET IN ONCOLOGY
Guest Editor: I. Carrio

The Quarterly Journal of Nuclear Medicine 2001 September;45(3):257-68

Evaluation of therapy response in breast and ovarian cancer patients by positron emission tomography (PET)

Baum R. P., Przetak Ch.

Abstract PDF

  PET IN ONCOLOGY
Guest Editor: I. Carrio

The Quarterly Journal of Nuclear Medicine 2001 September;45(3):269-73

Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between Non-Hodgkin’s Lymphoma and Hodgkin’s disease

Spaepen K., Mortelmans L.

Abstract

inizio pagina